GABA Transporter 1 (GAT1) (Middle Region) Peptid
GAT1
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle SLC6A1 (GAT1) Produkte
- SLC6A1 (GAT1) (GABA Transporter 1 (GAT1))
- Protein Region
- Middle Region
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- LIILFFRGVT LPGAKEGILF YITPNFRKLS DSEVWLDAAT QIFFSYGLGL
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-SLC6A1 Antibody(ARP43833_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SLC6A1 (GAT1) (GABA Transporter 1 (GAT1))
- Hintergrund
-
SLC6A1 terminates the action of GABA by its high affinity sodium-dependent reuptake into presynaptic terminals. This protein is the target of psychomotor stimulants such as amphetamines or cocaine.
Alias Symbols: GABATHG, GABATR, GAT1
Protein Interaction Partner: STX1A,STX1A
Protein Size: 599 - Molekulargewicht
- 67 kDa
- Gen-ID
- 6529
- NCBI Accession
- NM_003042, NP_003033
- UniProt
- P30531
-
Sie sind hier:
